Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients
Authors:
- 23 August 2017
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 20 (2) , 123-133
Abstract
BACKGROUND : The key regulator of tumor metabolome is the glycolytic isoenzyme M2-PK which favors the generation of nucleic acid via glutaminolysis as hypoxic adaptive mechanism in the tumor cells. AIM : The study aimed to evaluate the prognostic rolKeywords
This publication has 55 references indexed in Scilit:
- The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional studyNutrition Journal, 2013
- CA 15-3: Uses and limitation as a biomarker for breast cancerClinica Chimica Acta, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer ModelPLOS ONE, 2009
- Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supplyExperimental Cell Research, 2009
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- A systematic review of the association between circulating concentrations of C reactive protein and cancerJournal of Epidemiology and Community Health, 2007
- Inflammation and cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999